Fig. 3: Risk-stratified 2-year disease-free survival and overall survival. | Blood Cancer Journal

Fig. 3: Risk-stratified 2-year disease-free survival and overall survival.

From: A novel Iowa–Mayo validated composite risk assessment tool for allogeneic stem cell transplantation survival outcome prediction

Fig. 3

A Panels show significant difference in two-year DFS between low and high-risk patients stratified by the model at 76% and 40% in the training and 69% and 50% in the testing sets, respectively. B Panels show significant difference in two-year OS between the low- and high-risk patients stratified by the model at 76% and 47% and 75% and 56% among training and testing sets, respectively.

Back to article page